Bill Ciprick

Canadian licensed producer of GMP-grade psilocybin Optimi Health Corp. (OTCQX: OPTHF) closed a non-brokered private placement of 5,692,308 Optimi units at $0.236 each, for gross proceeds of $1.346.245 with Wilson Capital, the private equity division at Chip Wilson’s family office, and...

Health Canada receives applications concerning clinical trials on a regular basis.  This time, the licensed producer of natural EU-GMP psilocybin and MDMA Optimi Health Corp. (OTCQX: OPTHF) together with ATMA Journey Centers say they intend to submit a Phase I clinical trial...

Expert functional and magic mushrooms grower Optimi Health Corp. (OTCQX: OPTHF) has signed an agreement with Avida Global, a privately-held UK-based producer of white label products including nutraceuticals and medicinal cannabis oils. The deal entails Optimi will provide Avida with a large-...

Optimi Health (OTCQX: OPTHF) has released an operational update on its planned year of commercialization, including the launch of psychedelics catalog. Optimi is licensed by Health Canada as a producer and supplier of natural GMP psilocybin and synthetic psychedelic substances....

Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN), a Canadian-based company licensed by Health Canada to produce and supply natural psilocybin and other psychedelic substances, announced that it has entered into its first international psilocybin supply agreement with Promises...

Optimi Health Corp. (OTCQX: OPTHF) received permission from Health Canada to manufacture and distribute other psychedelic substances -most notably MDMA- under the amended terms outlined in its June 20, 2022 application to the institution. Optimi holds a license to produce...

The Canadian-based company licensed by Health Canada for psychedelic and functional mushrooms production, Optimi Health Corp. (OTCQX: OPTHF), together with psilocybin patient and advocate Thomas Hartle, are launching Blue Serenity, Canada’s first natural therapeutic psilocybin product. Coming...

Optimi Health Corp. (OTCQX: OPTHF), the Canadian licensed psychedelic and functional mushrooms producer has signed a partnership agreement with psilocybin patient advocate Thomas Hartle to produce a novel homegrown, natural therapeutic psilocybin product for approved patients. Who Is Thomas...

Canadian psychedelics company Optimi Health Corp. (OTCQX: OPTHF) signed a supply agreement with the Bloom Psychedelic Therapy And Research Centre, a Calgary-based provider of psychedelic-assisted therapies for mental health conditions. Optimi is a homegrown supplier of GMP psilocybin and...

Two publicly traded psychedelics companies announced supply agreements. HAVN Life Sciences (OTC: HAVLF) will provide mental health clinic MPB Group Inc. with psilocybin-containing mushrooms for its therapeutic retreats in Jamaica and Optimi Health Corp. (OTCQX: OPTHF) will supply...

Optimi Health Corp. (OTCQX: OPTHF), the Canadian company producing home-grown, scalable and accessible mushroom formulations, has recently signed another supply deal.  This time, the counterpart that is to receive Optimi’s natural mushrooms is ATMA Journey Centers, a facilitator of...

Optimi (OPTHF), the Canadian, home-grown mushroom formulations producer has signed not one but two supply deals with different research companies. The first involves Halucenex Life Sciences Inc. owned by Australian Creso Pharma (CPH). Halucenex’s mission involves...